Chipcytometry in a clinical setting

Post on 20-Feb-2017

272 views 1 download

Transcript of Chipcytometry in a clinical setting

ChipCytometry

Welcome!

Agenda

2

• 10:30 Arrival at Peter Medawar Building for Pathogen Research • 10:45 Chris Willberg: Welcome reception, introduction • 11:15 Christian Hennig: Introduction to Chipcytometry, Deep

Phenotyping and Tissue Cytometry • 11:45 Matthew Bilton: Analysis of MAIT cell populations within

mediastinal lymph nodes. • 12:15 Jan Detmers: Chipcytometry in a clinical setting • 12:30 Lunch • 13:15 visiting the lab • 14:00 Christian Hennig: Chipcytometry case studies, Q&A • 15:30 End of meeting

About

3

Zellkraftwerk GmbH

• Hannover, Germany

• 2 Divisions: Instrument Manufacturer – CRO

• CRO: Currently 4 phase I; 2 phase II trials

VA Partner

Central Lab Services

4

Fully automated analyzer

24/7 operation

4,000 data points/week

“Spirit of GLP”

Global Footprint

5

Sponsor

Central Lab BioBank ZellSafe™Box World Courier

Case Study (opticus neuritis)

6

Clinical Neuroimmunology

Clinical Neuroimmunology

7

- Disease: Multiple Scler.

- Study: Clinical

- Samples: 650

1. Round 2. Round

Outcome: - Stratification markers - Trial is ongoing

By courtesy of

Work Flow

8

2. Load - Load sample, wait 5‘ - Fix (4% PFA), wait 15‘ - rinse, seal chip

1. Prep - 1 ml blood - CPT, Ficoll or RBC lysis - total time: 40’

3. Store - store on-site - temperature 4°C - up to several months

4. Ship GDP Logistics (Good Distribution Practice)

5. Bioanalysis “Spirit of GLP” clinical trial

support (SOP, QA)

6. Re-interrogate Test additional markers over >24 months

Cell-based Biomarker Development

9

1: Study Preparation Phase

• SOP / Training Videos / Site Qualification

• On-site Training

2: Sample Collection Phase

• Custom kits with all consumables required

• Monthly / bi-monthly / quarterly sample pick-up according GDP

• Incoming sample QC and bio-banking analogous to GLP

3: Bioanalysis

• Assay / Method Development

• Method Validation analogous to GLP

• Sample analysis including ISR

• Option for sample re-interrogation for 24 months

4: Patient Stratification and Computational Biology

Preparing Clinical Trials

Candidate Sites 1, 2, 3, 4,..

2. Site Qualification Kit

1. SOP, Training Video

10

Collaborative Cytometry

Core Facility „Democratization“ Collaborate („go to an expert“) („have your own“) (“work with many”)

IT

FACS

11

Biomarker Development

12

Clinical Research Center Hannover

Method Development • Preanalytics • Assay Development • Data Processing • Data Management

Pilot Preparation

Planning • Study plan / IPC • IRB • Clinical Database • Site Audit

Clinical trial

Execution • Study Coordinator • Data Collection • Sample Analysis • Sample Logistics • Biobanking

Typical Milestone-based Project

13

Study Validation In-Study

Bioanalysis Work

Plan Panel Set-up

+ Controls

Samples Ideas

Thank you for your attention!

14

Selected Primary Publications

• Happle, Science Translational, 2014

• Dijkstra, Nature Medicine 2012

• Hennig, Br. J. Hematology 2010

• Woelbeling, Immunobiology 2011

• Polte, JACI 2008

System Validation according to:

• O'Hara, JIM 2011

• Green, JIM 2011

• Cunliffe, Pharm. Res. 2009

• Lee, Pharm. Res. 2006

• Bioanalytical Method Validation, FDA, 2013

“Precision Immunology” References

A B C Control Diseased Groups Group

Focus on: Translational Immunology Mode of Action(MoA) Patient Stratification Clinical Trial Support